Author:
Jafari-Sales Abolfazl,Al-Khafaji Noor S.K.,Al-Dahmoshi Hussein O.M.,Sadeghi Deylamdeh Zahra,Akrami Sousan,Shariat Afsoon,Judi Hawraa K.,Nasiri Rozita,Bannazadeh Baghi Hossein,Saki Morteza
Abstract
Abstract
Objectives
This study aimed to evaluate the antibiotic resistance patterns and prevalence of carbapenemase genes in Klebsiella pneumoniae isolates in different clinical samples from Tabriz city, northwestern Iran.
Results
This cross-sectional study was conducted in the Department of Microbiology, Islamic Azad University, Ahar Branch, Iran, in 2020. K. pneumoniae isolates were collected from different clinical samples, including blood, wounds, sputum, and urine. The isolates were identified using a series of standard bacteriological tests. Antibiotic resistance was determined by the disc diffusion method. The presence of blaVIM, blaNDM, blaKPC, blaOXA, and blaIMP genes were screened by polymerase chain reaction (PCR). A total of 100 non-duplicated K. pneumoniae isolates were collected from 57 urine samples, 27 blood samples, 13 wound samples, and 3 sputum samples. Overall, 70.0% of the samples were from inpatients, while 30.0% were from outpatients. The most resistance rate was related to ampicillin (94.0%), while the lowest resistance rate was related to imipenem (18.0%) and meropenem (20.0%). Overall, 25.0% of the isolates were carbapenem-resistant, of which 13.0% were resistant to both imipenem and meropenem. The PCR showed the total prevalence of 23.0% for carbapenemase genes, including 18.0% for blaKPC, 3.0% for blaVIM, 1.0% for blaIMP, and 1.0% for blaOXA gene. The blaNDM gene was not detected in any isolate. The prevalence of carbapenemase-producing K. pneumoniae isolates was relatively lower in northwestern Iran than in other regions of the country. However, special attention should be paid to the proper use of antibiotics, particularly carbapenems, to prevent further spread of antibiotic resistance and its related genes.
Publisher
Springer Science and Business Media LLC
Subject
General Biochemistry, Genetics and Molecular Biology,General Medicine
Reference35 articles.
1. Choby J, Howard-Anderson J, Weiss D. Hypervirulent Klebsiella pneumoniae–clinical and molecular perspectives. J Intern Med. 2020;287(3):283–300.
2. Jafari-Sales A, Soleimani H, Moradi L. Antibiotic resistance pattern in Klebsiella pneumoniae strains isolated from children with urinary tract Infections from Tabriz hospitals. Health Biotechnol Biopharma. 2020;4(1):38–45.
3. Ramachandran G, Rajivgandhi GN, Murugan S, Alharbi NS, Kadaikunnan S, Khaled JM, et al. Anti-carbapenamase activity of Camellia japonica essential oil against isolated carbapenem resistant Klebsiella pneumoniae (MN396685). Saudi J Biol Sci. 2020;27(9):2269.
4. Hammoudi Halat D, Ayoub Moubareck C. The current burden of carbapenemases: review of significant properties and dissemination among gram-negative bacteria. Antibiotics. 2020;9(4):186.
5. Cowan ST. Cowan and Steel’s manual for the identification of medical bacteria. Cambridge university press; 2003.